Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials
Federica Fogacci, Giuseppe Danilo Norata, Peter P. Tóth, Marcello Arca, Arrigo F.G. Cicero
Topics & Concepts
MedicineInternal medicineApolipoprotein BGastroenterologyVery low-density lipoproteinConfidence intervalCholesterolLipoproteinLipoproteins and Cardiovascular HealthComputational Drug Discovery MethodsPARP inhibition in cancer therapy